| Apr 10 2024 |
United States | USCIS Lifts Limits to Form I-693 Validity Period |
Berry Appleman & Leiden |
| Apr 10 2024 |
Floridians to Decide Fate of Adult-Use Marijuana This November |
Bradley Arant Boult Cummings LLP |
| Apr 10 2024 |
Women’s Sport Round Up (UK) |
Squire Patton Boggs (US) LLP |
| Apr 10 2024 |
Private Equity: Proposed Health Over Wealth Act -What This Means for You |
Foley & Lardner LLP |
| Apr 10 2024 |
Employment Law This Week Episode 341 - Union Reps at OSHA Inspections, New COVID-19 Guidance, and Minimum Wage Updates [Video, Podcast] |
Epstein Becker & Green, P.C. |
| Apr 10 2024 |
California Considers Workers’ Compensation Heat Illness Presumption for Agricultural Workers |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 9 2024 |
This Week in 340B: April 2 – April 8, 2024 |
McDermott Will & Schulte LLP |
| Apr 9 2024 |
EPA’s Focus on Ethylene Oxide |
Blank Rome LLP |
| Apr 9 2024 |
PBM Policy and Legislative Update — Winter 2024 |
Mintz |
| Apr 9 2024 |
Corporate Practice of Medicine Doctrine: Part 1 [Podcast] |
K&L Gates LLP |
| Apr 9 2024 |
Texas Bankruptcy Court Declines to Deem Nonvotes as Votes in Favor of Plan (US) |
Squire Patton Boggs (US) LLP |
| Apr 9 2024 |
California Greatly Expands List of Cosmetics Fragrances Reportable as Allergens |
ArentFox Schiff LLP |
| Apr 9 2024 |
Is Your Business in Compliance with Washington’s New Data Privacy Statute? |
Blank Rome LLP |
| Apr 9 2024 |
Washington State: 2024 Spring Legislative Roundup |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 8 2024 |
Updated Requirements for Informed Consent: HHS Issues New Guidance on Sensitive Exams |
Epstein Becker & Green, P.C. |
| Apr 8 2024 |
Employers Take Note: OSHA Publishes Final “Walkaround” Rules |
Foley & Lardner LLP |
| Apr 8 2024 |
Healthcare Preview for the Week of: April 8, 2024 [PODCAST] |
McDermott Will & Schulte LLP |
| Apr 8 2024 |
Healthcare Highlights from FTC’s 2024 PrivacyCon |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 8 2024 |
Closing the Loopholes: The Biden-Harris Administration’s Action Against “Junk Insurance” |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 5 2024 |
McDermottPlus Check-Up: April 5, 2024 |
McDermott Will & Schulte LLP |
| Apr 5 2024 |
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act |
Greenberg Traurig, LLP |
| Apr 5 2024 |
CMS ISSUES ITS 2025 FINAL RULE: Aligning with the FCC, CMS Requires TPMOs to Obtain Beneficiary’s Prior Express Written Consent Prior to Sharing Personal Data with Other TPMOs – Even if “Manually” Dialing! |
Troutman Amin, LLP |
| Apr 5 2024 |
As Temperatures Start to Rise, OSHA Takes Steps to Implement Rules Concerning Heat Illness Prevention |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 5 2024 |
Anti-Kickbacks, Pro Patients: Whistleblower Exposes Oncology Practice’s Kickback Scheme |
Tycko & Zavareei LLP |
| Apr 4 2024 |
Washington State and Seattle Paid Sick and Safe Leave Updates |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 4 2024 |
Pack Rat Shareholders: Dealing with Hoarding in Cooperatives |
Norris McLaughlin P.A. |
| Apr 4 2024 |
HHS Health Care Cybersecurity Performance Goals: Proposed Incentives, Penalties and Compliance Standards Review |
Mintz |
| Apr 4 2024 |
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective |
Foley & Lardner LLP |
| Apr 4 2024 |
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements |
Greenberg Traurig, LLP |
| Apr 3 2024 |
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 3 2024 |
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO |
Mintz |
| Apr 3 2024 |
Two New Proposed Rules for Medicare Advantage Plans Expands Beneficiary Rights |
Norris McLaughlin P.A. |
| Apr 3 2024 |
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation |
Greenberg Traurig, LLP |
| Apr 3 2024 |
Continuity in Coverage: CMS Extends the Unwinding SEP & Issues Final Rule for Medicaid and CHIP Enrollment |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 3 2024 |
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
